Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Immunogenicity, Safety, Poliovirus Excretion and Acceptance of Vaccination OPV (Vero Cells) in Newborns Mexicans

NCT01870206 is registered in ClinicalTrials.gov with Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. as lead sponsor.

NCT NCT01870206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01870206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Immunogenicity, Safety, Poliovirus Excretion and Acceptance of Vaccination OPV (Vero Cells) in Newborns Mexicans
Lead sponsor
Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2013
Completion date
January 31, 2014
Enrollment
320 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

poliomyelitis